MD Research
Long/short equity, integrated investing, 360 Biotech, insightful news

A Medical Doctor's Perspective On MannKind Corp.'s Revolutionary Diabetes Mellitus Treatments

Introduction

MannKind Corporation (NASDAQ:MNKD), a small cap biotechnology in Valencia, California, planted the catalytic seeds for revolutionary diabetes treatment more than a decade ago that are now materializing for aggressive growth. In this research report, the author will provide a c...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
WITH SEEKING ALPHA PRO, INVESTORS CAN ALSO:
  • Access Top Ideas, chosen by Seeking Alpha’s editors
  • Filter long and short ideas by market cap and sector
  • Get Coverage of over 5,000 stocks, many of which have little or no coverage elsewhere
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO." Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else." Patrick Rice, Mainstay Capital Management
100% Satisfaction Guaranteed
You are protected by the Seeking Alpha Money Back Guarantee and will get a prompt refund on the unused portion of your subscription at any time, for any reason.